Abstract:Protein aggregation is a widespread phenomenon implicated in debilitating diseases like Alzheimer's, Parkinson's, and cataracts, presenting complex hurdles for the field of molecular biology. In this review, we explore the evolving realm of computational methods and bioinformatics tools that have revolutionized our comprehension of protein aggregation. Beginning with a discussion of the multifaceted challenges associated with understanding this process and emphasizing the critical need for precise predictive tools, we highlight how computational techniques have become indispensable for understanding protein aggregation. We focus on molecular simulations, notably molecular dynamics (MD) simulations, spanning from atomistic to coarse-grained levels, which have emerged as pivotal tools in unraveling the complex dynamics governing protein aggregation in diseases such as cataracts, Alzheimer's, and Parkinson's. MD simulations provide microscopic insights into protein interactions and the subtleties of aggregation pathways, with advanced techniques like replica exchange molecular dynamics, Metadynamics (MetaD), and umbrella sampling enhancing our understanding by probing intricate energy landscapes and transition states. We delve into specific applications of MD simulations, elucidating the chaperone mechanism underlying cataract formation using Markov state modeling and the intricate pathways and interactions driving the toxic aggregate formation in Alzheimer's and Parkinson's disease. Transitioning we highlight how computational techniques, including bioinformatics, sequence analysis, structural data, machine learning algorithms, and artificial intelligence have become indispensable for predicting protein aggregation propensity and locating aggregation-prone regions within protein sequences. Throughout our exploration, we underscore the symbiotic relationship between computational approaches and empirical data, which has paved the way for potential therapeutic strategies against protein aggregation-related diseases. In conclusion, this review offers a comprehensive overview of advanced computational methodologies and bioinformatics tools that have catalyzed breakthroughs in unraveling the molecular basis of protein aggregation, with significant implications for clinical interventions, standing at the intersection of computational biology and experimental research.

Molecular mechanisms of protein aggregation from global fitting of kinetic models

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Kinetic Analysis of Amyloid Formation

A Kinetic Study of Amyloid Formation

Kinetic models reveal the interplay of protein production and aggregation

A generic approach to decipher the mechanistic pathway of heterogeneous protein aggregation kinetics

Statistical Mechanical Treatments of Protein Amyloid Formation

Model for competing pathways in protein-aggregation: role of membrane bound proteins

Mechanisms and pathology of protein misfolding and aggregation

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors

Computational simulations of the early steps of protein aggregation.

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

Computational Simulations of the Early Steps of Protein Aggregation

Computational studies of protein aggregation mediated by amyloid: Fibril elongation and secondary nucleation

Molecular determinants of protein pathogenicity at the single-aggregate level

A Statistical Mechanical Approach to Protein Aggregation

Statistical Mechanical Approach to Protein Aggregations

Pathways of amyloid fibril formation and protein aggregation

Advanced computational approaches to understand protein aggregation

Non-native beta-sheet formation: insights into protein amyloidosis